2,390
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Portrayals of 2v, 4v and 9vHPV vaccines on Chinese social media: a content analysis of hot posts on Sina Weibo

ORCID Icon, ORCID Icon, &
Pages 4433-4441 | Received 18 May 2021, Accepted 16 Aug 2021, Published online: 20 Sep 2021

References

  • World Health Organisation. Vaccine in national immunization programme update; 2020 [accessed 2021 Mar 27]. www.who.int/entity/immunization/monitoring_surveillance/VaccineIntroStatus.pptx .
  • Pan SY, Zhang D, Zhang JW. caught in the crossfire: how contradictory information and norms on social media influence young women’s intentions to receive HPV vaccination in the United States and China. Front Psychol. 2020;11:14. doi:10.3389/FPSYG.2020.548365.
  • Wang Q, Zhang W, Cai HN, Cao Y. Understanding the perceptions of Chinese women of the commercially available domestic and imported HPV vaccine: a semantic network analysis. Vaccine. 2020;38:8334–42. doi:10.1016/J.VACCINE.2020.11.016.
  • Schiller JT, Castellsague X, Garland SM. A review of clinical trials of Human Papillomavirus prophylactic vaccines. Vaccine. 2012;30:F123–F38. doi:10.1016/j.vaccine.2012.04.108.
  • Luxembourg A, Moeller E. 9-Valent human papillomavirus vaccine: a review of the clinical development program. Expert Rev Vaccines. 2017;16:1119–39. doi:10.1080/14760584.2017.1383158.
  • BJNEWS. HPV vaccines are hard to get, when can an appointment be made? 2020. [accessed 2021 Mar 27]. https://www.bjnews.com.cn/detail/159617396715715.html .
  • China Vaccine. China’s HPV vaccination rate is lower than that of Rwanda, experts call for free vaccination; 2018. [accessed 2021 Mar 27]. https://www.cnvax.com/t/10525 .
  • CCTV. State food and drug administration: prevention of cervical cancer should not only focus on the nine price HPV vaccine; 2019. [accessed 2021 Mar 27]. http://news.cctv.com/2019/07/06/ARTI75yjwnGtagXohu61Z2J0190706.shtml .
  • Zhongmin. Domestic HPV vaccines will be open for appointment from May! How to make an appointment and what should be paid attention to? 2020. [accessed 2021 Mar 27]. https://www.zhongmin.cn/news/detail_55467.html .
  • Tencent Prism. Failure appointment in HPV vaccines similar to license plate lottery; 2020. [accessed 2021 Mar 27]. https://xueqiu.com/6718098612/157371719 .
  • Xinmin Evening News. It’s hard to book 4v and 9vHPV vaccines! Expert says why not consider domestic bivalent vaccine; 2021. [accessed 2021 Jul 20]. http://wap.xinmin.cn/content/31979311.html .
  • 18:00NEWS. The success rate of 9vHPV vaccine lottery is 1.7%, and the supply will increase this year; 2020. [accessed 2021 July 22]. http://static.scms.sztv.com.cn/ysz/dsdb/ggpd/18dxw/78184507.shtml .
  • China Newsweek. 420,000 people participated in the Vaccine Lottery, success rate less than 2%. Why is HPV vaccine so hard to get? 2021. [accessed 2021 July 22]. http://www.inewsweek.cn/kj/2021-07-13/13197.shtml .
  • China Vaccine. Supply of Gardasil 9 is shortage, and supply to Hong Kong will be suspended in the next month; 2017. [accessed 2021 Mar 27]. https://www.cnvax.com/t/10472 .
  • Zeng Z, Yang H, Li Z, He X, Griffith CC, Chen X, Guo X, Zheng B, Wu S, Zhao C, et al. Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV genotyping results from China’s largest CAP certified laboratory. J Cancer. 2016;7:1037–43. doi:10.7150/jca.14971.
  • Lo KWK, Wong YF, Chan MKM, Li JCB, Poon JS, Wang VW, Zhu SN, Zhang TM, He ZG, Wu QL, et al. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer. 2002;100(3):327–31. doi:10.1002/ijc.10506.
  • Xing J, Tan T, Guo YL, Zhu JQ, Zheng AW, Yu AJ, Niu Z. Heat maps present the spatial distribution of human papillomavirus infection in Zhejiang Province, China. Oncol Lett. 2021;21:6. doi:10.3892/OL.2021.12627.
  • Liao GD, Jiang XY, She B, Tang HJ, Wang ZY, Zhou HR, Ma Y, Xu W, Xu H, Chen W, et al. Multi-infection patterns and co-infection preference of 27 human papillomavirus types among 137,943 gynecological outpatients across China. Front Oncol. 2020;10:9. doi:10.3389/FONC.2020.00449.
  • Wang ZL, Gu Y, Wang H, Chen JY, Zheng YW, Cui BX, Yang X. Distribution of cervical lesions in high-risk HPV (hr-HPV) positive women with ASC-US: a retrospective single-center study in China. Virol J. 2020;17(1):10. doi:10.1186/S12985-020-01455-2.
  • Zheng Y, Fan YG, Zeng Y, Liu SY, Gao LM. Different genotype distribution of human papillomavirus between cervical and esophageal cancers: a study in both high-incidence areas, Xinjiang, China. Biomed Res Int. 2020;2020:7. doi:10.1155/2020/7926754.
  • Guo C, Du H, Belinson JL, Wang C, Huang X, Qu X, Wu R. The prevalence and distribution of human papillomavirus among 10,867 Chinese Han women. Infect Agent Cancer. 2021;16(1):21. doi:10.1186/S13027-021-00360-9.
  • Tracy L, Gaff HD, Burgess C, Sow S, Gravitt PE, Tracy JK. Estimating the impact of Human Papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali. Clinical Infectious Diseases. 2011;52:641–45. doi:10.1093/cid/ciq190.
  • CCTV. Experts say the prevention and control rate of 2vHPV vaccine reached 84.5%. It is recommended to vaccinate as soon as possible; 2021. [accessed 2021 Jul 20]. https://news.cctv.com/2021/07/19/ARTIBl0E7qzylfCF4SAtZV5O210719.shtml .
  • Marlow LAV, Waller J, Wardle J. Trust and experience as predictors of HPV vaccine acceptance. Hum Vaccin. 2007;3:171–75. doi:10.4161/hv.3.5.4310.
  • Liu SS, Liu Y, Zhang T, Wang L, Huang JL, Liang H, Chen G, Liu CJ, Zhang YM. The developing family doctor system: evidence from the progress of the family doctor signing service from a longitudinal survey (2013-2016) in Pudong New Area, Shanghai. BMC Fam Pract. 2021;22. doi:10.1186/S12875-020-01353-0.
  • Li WB, Nowak G, Jin Y, Inadequate CM. Incomplete: Chinese Newspapers’ coverage of the first licensed Human Papillomavirus (HPV) vaccine in China. J Health Commun. 2018;23:581–90. doi:10.1080/10810730.2018.1493060.
  • Lu XY. Lessons from Weibo: media convergence and contemporary Chinese politics. Javnost-Public. 2020;27:126–39. doi:10.1080/13183222.2020.1728492.
  • Ortiz RR, Smith A, Coyne-Beasley T. A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination. Human Vaccines Immunother. 2019;15:1465–75. doi:10.1080/21645515.2019.1581543.
  • Kang GJ, Ewing-Nelson SR, Mackey L, Schlitt JT, Marathe A, Abbas KM, et al. Semantic network analysis of vaccine sentiment in online social media. Vaccine. 2017;35:3621–38. doi:10.1016/j.vaccine.2017.05.052.
  • Luisi MLR. From bad to worse: the representation of the HPV vaccine Facebook. Vaccine. 2020;38:4564–73. doi:10.1016/j.vaccine.2020.05.016.
  • Agergaard TE, Smith ME, Nielsen KH. Vaccine assemblages on three HPV vaccine-critical Facebook pages in Denmark from 2012 to 2019. Media Commun. 2020;8:339–52. doi:10.17645/mac.v8i2.2858.
  • Zhang CP, Gotsis M, Jordan-Marsh M. Social media microblogs as an HPV vaccination forum. Human Vaccines Immunother. 2013;9:2483–89. doi:10.4161/hv.25599.
  • Li JH, Zheng H. Coverage of HPV-related information on Chinese social media: a content analysis of articles in Zhihu. Human Vaccines Immunother. 2020;16:2548–54. doi:10.1080/21645515.2020.1729028.
  • Su XL. Content analysis of HPV vaccine messages on Chinese social media. J Messenger. 2020;12:63–73. doi:10.26623/themessenger.v12i1.1814.
  • Leader AE, Burke-Garcia A, Massey PM, Roark JB. Understanding the messages and motivation of vaccine hesitant or refusing social media influencers. Vaccine. 2021;39:350–56. doi:10.1016/J.VACCINE.2020.11.058.
  • Tian XY, Batterham P, Song S, Yao XX, Yu G. Characterizing depression issues on Sina Weibo. Int J Environ Res Public Health. 2018;15:11. doi:10.3390/ijerph15040764.
  • Wei L, Hu YM. Issue presentation in the Chinese microblogosphere: an empirical study of Sina Hot Weibo. J Zhejiang University. 2014;44:41–52.
  • Zhang Y, Li B, Liu CY. Topic-oriented monitoring of public sentiment towards popular Weibo events—A case study on regular ‘Odd-even’ vehicle restriction in Beijing. J Chin Inform Proc. 2015;29(5):143–151+159. CNKI:SUN:MESS.0.2015-05-020.
  • Wang JZ, Zhou Y, Zhang W, Evans R, Zhu CY. Concerns expressed by Chinese social media users during the COVID-19 pandemic: content analysis of Sina Weibo microblogging data. J Med Internet Res. 2020;22:13. doi:10.2196/22152.
  • Lee D, Hosanagar K, Nair HS. Advertising content and consumer engagement on social media: evidence from Facebook. Manage Sci. 2018;64:5105–31. doi:10.1287/mnsc.2017.2902.
  • DiVoMiner. What is DiVoMiner? 2019. [accessed 2021 Mar 27]. https://me.divominer.cn/#/home
  • Wang D, Guo ZS. Framing and construal level: a comparative analysis of press coverage of China’s “One Belt One Road” initiative. Journalism & Communication. 2020;27:5–20+126. CNKI:SUN:YANJ.0.2020-03-001.
  • CCTV. China’s first cervical cancer vaccine approved, expected to be officially launched early next year; 2016. [accessed 2021 Mar 27]. http://news.cctv.com/2016/07/21/ARTI2Je014Umdh3wf9sHjNwb160721.shtml .
  • Sohu. Merck 4vHPV cervical cancer vaccine Gardasil will be launched in China soon; 2017. [accessed 2021 Mar 27]. https://www.sohu.com/a/141863935_464396 .
  • CCTV. 2vHPV cervical cancer vaccine in main land China; 2017. [accessed 2021 Mar 27]. http://news.cctv.com/2017/08/02/ARTIYwPMM8F22QCExTM6zgrM170802.shtml .
  • Sina medicine. Merck 4vHPV vaccine started to fight for cervical cancer vaccine market; 2017. [accessed 2021 Mar 27]. https://med.sina.com/article_detail_100_2_36588.html .
  • CCTV. The 9-valent cervical cancer vaccine was approved in only 8 days, with its price slightly higher than the international level; 2018. [accessed 2021 Mar 27]. http://news.cctv.com/2018/05/17/ARTIZ6bHapKl8MxreHGGQTYZ180517.shtml .
  • CCTV. Bid farewell to import dependence, the first domestic 2vHPV cervical cancer vaccine has been approved for marketing, which can be vaccinated at the age of 9-45; 2020. [accessed 2021 Mar 27]. http://news.cctv.com/2020/01/02/ARTI9pAYirz0Z7wwyWbsvdMP200102.shtml .
  • Cha M, Haddadi H, Benevenuto F, Gummadi KP. Measuring user influence in Twitter: the million follower fallacy. Paper presented at the AAAI 2010, Georgia, USA; 2010, July 11-15.
  • Yu H, Construction MX. Steering of risk issues in social media context: a study case of Shandong vaccine incident. J Intelligence. 2017;36(3):79–85. CNKI:SUN:QBZZ.0.2017-03-039.
  • Hoffman BL, Fetter EM, Chu KH, Shensa A, Hermann C, Wolynn T, Williams D, Primack BA. It’s not all about autism: the emerging landscape of anti-vaccination sentiment on Facebook. Vaccine. 2019;37(16):2216–23. doi:10.1016/j.vaccine.2019.03.003.
  • Zhou M, Qu SJ, Zhao LD, Kong N, Campy KS, Wang S. Trust collapse caused by the Changsheng vaccine crisis in China. Vaccine. 2019;37(26):3419–25. doi:10.1016/j.vaccine.2019.05.020.
  • Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Global Health. 2020;5(10):e004206. doi:10.1136/bmjgh-2020-004206.
  • Hu D, Martin C, Dredze M, Broniatowski DA. Chinese social media suggest decreased vaccine acceptance in China: an observational study on Weibo following the 2018 Changchun Changsheng vaccine incident. Vaccine. 2020;38:2764–70. doi:10.1016/j.vaccine.2020.02.027.
  • Cao L, Zheng JS, Cao LS, Cui J, Xiao QY. Evaluation of the impact of Shandong illegal vaccine sales incident on immunizations in China. Human Vaccines Immunother. 2018;14:1672–78. doi:10.1080/21645515.2018.1473697.
  • Xiao X, Su Y. Still a “female problem”: a framing analysis of the Human Papillomavirus (HPV) vaccine in Chinese online news. Chin J Comm. 2020;13:275–92. doi:10.1080/17544750.2020.1714683.
  • Zhang W, Wang Q. The failure of news coverage supportive of human papillomavirus vaccination: the investigation of the effects of online comments on female college students” vaccination intention. Vaccine. 2019;37:5681–87. doi:10.1016/j.vaccine.2019.08.007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.